InvestorsHub Logo
Followers 0
Posts 160
Boards Moderated 0
Alias Born 09/04/2012

Re: hovacre post# 37245

Thursday, 10/05/2017 8:49:14 AM

Thursday, October 05, 2017 8:49:14 AM

Post# of 108192
I have spoken with Noelle about the HER-2 human trial where it was being used for multiple HER-2 cancers. The human trial was ongoing. The company decided to stop pursuing HER-2 because the next step was a study in pediatric osteosarcoma which is a very small market. As much as the company would like to help those patients, it needs to conserve and prioritize the use of its resources. The efficacy data from the human HER-2 trial is being compiled and will be released at some point in the future.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News